Beam Therapeutics · 1 week ago
CryoEM Image Analysis Intern
Beam Therapeutics is a biotechnology company focused on precision genetic medicines. They are seeking an enthusiastic Intern to support the Analytical Research & Development team in developing image processing pipelines for Cryo-electron microscopy data analysis and interpretation.
BiotechnologyGeneticsMedicalTherapeutics
Responsibilities
Design and execute cryoEM data analysis in collaboration with internal and external scientists
Maintain good records of data processing pipeline development
Perform data analysis and visualization using appropriate software
Build customized data processing pipelines when necessary
Present findings at cross-functional team meetings
Qualification
Required
Demonstrates strong communication and interpersonal skills
Background in image processing is required
Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the internship to be eligible
Preferred
Experience with cryoEM and data analysis tools (such as Amira) is a plus
Familiarity with characterization of drug delivery vehicles, such as lipid nanoparticles is a plus
Suitable majors for this role include Biophysics, Bioinformatics, Computational Biology, and related fields
Company
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
H1B Sponsorship
Beam Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (9)
2023 (12)
2022 (9)
2021 (7)
2020 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.19B2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M
Recent News
2026-01-13
2025-12-16
Company data provided by crunchbase